borderline significanceP = .08
Nonetheless, the case group had lower mean ALT levels during chemotherapy, with borderline significance (mean ALT levels of 24.17 declined to 22.60 versus mean ALT levels of 22.70 increased to 26.33, P = .08).
Nonetheless, the case group had lower mean ALT levels during chemotherapy, with borderline significance (mean ALT levels of 24.17 declined to 22.60 versus mean ALT levels of 22.70 increased to 26.33, P = .08).